Patents by Inventor Pavlos Alifragis

Pavlos Alifragis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11624066
    Abstract: The invention relates to neurodegenerative disorders, and in particular to novel oligonucleotides for treating such conditions, for example Alzheimer's disease. The invention provides novel antisense oligonucleotides, and compositions comprising such oligos, and therapies and methods for treating neurodegenerative disorders. The invention includes genome editing techniques for achieving similar results as using the novel antisense oligonucleotides.
    Type: Grant
    Filed: February 25, 2019
    Date of Patent: April 11, 2023
    Assignee: Teesside University
    Inventors: Pavlos Alifragis, Linda Popplewell, John George Dickson, Amninder Sangha
  • Publication number: 20210002639
    Abstract: The invention relates to neurodegenerative disorders, and in particular to novel oligonucleotides for treating such conditions, for example Alzheimer's disease. The invention provides novel antisense oligonucleotides, and compositions comprising such oligos, and therapies and methods for treating neurodegenerative disorders. The invention includes genome editing techniques for achieving similar results as using the novel antisense oligonucleotides.
    Type: Application
    Filed: February 25, 2019
    Publication date: January 7, 2021
    Inventors: Pavlos Alifragis, Linda Popplewell, George Dickson, Amninder Sangha